ARCHIVES

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

This article is from The Cancer Letter archive.

Vol. 39 No. 44 | November 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat.

February 6, 2004

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011